# ROPINIROLE HYDROCHLORIDE
> **ANDA204413** · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON INC · Approved 2022-05-11
## Drug
- **FDA Application Number:** ANDA204413
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ROPINIROLE HYDROCHLORIDE
- **Generic name:** ROPINIROLE
- **Active ingredients:** ROPINIROLE HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PRINSTON INC
- **Manufacturer:** Solco Healthcare US, LLC
- **First approval:** 2022-05-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204413)
---
*AI Analytics · CC0 1.0*